Tech Times on MSN
HER2-positive breast cancer trial reports 92% survival in chemo-free patients; proof pending
HER2-positive breast cancer chemotherapy can be safely omitted in about 30% of patients, five-year PHERGain trial data ...
A breakthrough in the fight against mosquito-borne viruses could one day help protect patients from devastating neurological complications.
The WHO estimated over 800,000 suicide deaths in 2012, with poisoning a major concern. Three‑quarters of suicides occur in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results